Chiral pharmaceuticals: A review on their environmental ......copyediting, typesetting, and review...

Post on 01-Mar-2021

1 views 0 download

Transcript of Chiral pharmaceuticals: A review on their environmental ......copyediting, typesetting, and review...

Accepted Manuscript

Chiral pharmaceuticals: A review on their environmental occurrence and fateprocesses

Edmond Sanganyado, Zhijiang Lu, Qiuguo Fu, Daniel Schlenk, Jay Gan

PII: S0043-1354(17)30656-5

DOI: 10.1016/j.watres.2017.08.003

Reference: WR 13126

To appear in: Water Research

Received Date: 14 May 2017

Revised Date: 1 August 2017

Accepted Date: 2 August 2017

Please cite this article as: Sanganyado, E., Lu, Z., Fu, Q., Schlenk, D., Gan, J., Chiral pharmaceuticals:A review on their environmental occurrence and fate processes, Water Research (2017), doi: 10.1016/j.watres.2017.08.003.

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service toour customers we are providing this early version of the manuscript. The manuscript will undergocopyediting, typesetting, and review of the resulting proof before it is published in its final form. Pleasenote that during the production process errors may be discovered which could affect the content, and alllegal disclaimers that apply to the journal pertain.

This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

β

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUS CRIP T

ACCEP TED

ACCEPTED MANUSCRIPT

35

8 References 740

Aboul-Enein, H.Y., Ali, I., 2002. Chiral resolution of clenbuterol, cimaterol, and mabuterol on 741 Chirobiotic V, T, and TAG columns. J. Sep. Sci. 25, 851–855. 742

Agranat, I., Caner, H., Caldwell, J., 2002. Putting chirality to work: the strategy of chiral 743 switches. Nat. Rev. Drug Discov. 1, 753–68. 744

Ali, I., Saleem, K., Hussain, I., Gaitonde, V.D., Aboul Enein, H.Y., 2009a. Polysaccharides 745 chiral stationary phases in liquid chromatography. Sep. Purif. Rev. 38, 97–147. 746

Ali, I., Singh, P., Aboul-Enein, H.Y., Sharma, B., 2009b. Chiral analysis of ibuprofen residues in 747 water and sediment. Anal. Lett. 42, 1747–1760. 748

Allenmark, S., Gawronski, J., 2008. Determination of absolute configuration—An overview 749 related to this Special Issue. Chirality 20, 606–608. 750

Amorim, C.L., Moreira, I.S., Ribeiro, A.R., Santos, L.H.M.L.M., Delerue-Matos, C., Tiritan, 751 M.E., Castro, P.M.L., 2016. Treatment of a simulated wastewater amended with a chiral 752 pharmaceuticals mixture by an aerobic granular sludge sequencing batch reactor. Int. 753 Biodeterior. Biodegrad. 115, 277–285. doi:10.1016/j.ibiod.2016.09.009 754

Ardakani, Y.H., Mehvar, R., Foroumadi, A., Rouini, M.-R., 2008. Enantioselective 755 determination of tramadol and its main phase I metabolites in human plasma by high-756 performance liquid chromatography. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 757 864, 109–15. 758

Ariens, E.I., Wuis, E.W., Veringa, E.I., 1988. Stereoselectivity of bioactive xenobiotics: A pre-759 pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. 760 Biochem. Pharmacol. 37, 9–18. 761

Ariëns, E.J., 1986. Chirality in bioactive agents and its pitfalls. Trends Pharmacol. Sci. 7, 200–762 205. 763

Ariëns, E.J., 1984. Stereochemistry: A basis for sophisticated nonsense in pharmacokinetics and 764 clinical pharmacology. Eur. J. Clin. Pharmacol. 26, 663–668. 765

Arnold, K.E., Boxall, A.B.A., Brown, A.R., Cuthbert, R.J., Gaw, S., Thomas, H., Jobling, S., 766 Madden, J.C., Metcalfe, C.D., Naidoo, V., Shore, R.F., Smits, J.E., Taggart, M.A., 767 Thompson, H.M., 2013. Assessing the exposure risk and impacts of pharmaceuticals in the 768 environment on individuals and ecosystems Assessing the exposure risk and impacts of 769 pharmaceuticals in the environment on individuals and ecosystems. Biol. Lett. 9, 20130492. 770

Awad, H., El-aneed, A., 2013. Enantioselectivity of mass spectrometry: Challenges and 771 promises. Mass Spectrom. Rev. 32, 466–483. doi:10.1002/mas.21379 772

Bagnall, J., Malia, L., Lubben, A., Kasprzyk-Hordern, B., 2013. Stereoselective biodegradation 773

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT

MANUSCRIP

T

ACCEPTED

ACCEPTED MANUSCRIPT